Delivery Order SPE2DB20D2014-SPE2DB25FB11L

Award Date 2/19/25
Potential Completion Date 2/20/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of BUPRENORPHINE 20 MCG/HR PATCH 4S to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on October 17, 2024 with a ceiling value of $1,211.98. The contract is a Delivery Order under a Firm Fixed Price arrangement and has an ultimate completion date of October 18, 2024. This award is not designated as a set-aside...
This federal contract award is for the delivery of Buprenorphine 20 mcg/hr patches to the Defense Logistics Agency (DLA). The $1,658.72 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on April 13, 2023. The contract has an ultimate completion date of April 14, 2023 and was not designated as a set-aside. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a $999,999,999 Indefinite Delivery...
This federal contract award, valued at $1,322.64, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Buprenorphine 7.5 MCG/HR Patch, a specialty pharmaceutical product used for pain management. This contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at...
This federal contract award is for the delivery of Buprenorphine 15 MCG/HR Patch 4S, a pain management medication, to the Defense Logistics Agency (DLA). The $2,422.28 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 1, 2021, with a completion date of November 2, 2021. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
This federal contract award is for the delivery of Buprenorphine 10 MCG/HR Patch 4S, a medication used for pain management. The contract, valued at $1,968.62, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order placed under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen's parent company, Cencora, Inc., and the Defense Logistics Agency (DLA) Troop Support Medical, valued at up...
This federal contract award is for the delivery of Buprenorphine 20 mcg/hr Patches to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with no set-aside designation, indicating open competition. The contract has a ceiling value of $2,519.08 and an ultimate completion date of August 21, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also...
This federal contract award, with ID SPE2DX15D2213|SPE2DX24F7X9X, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,954,459 units of Buprenorphine 20 mcg/hr Patches. The award has a ceiling value of $1,056.00 and an ultimate completion date of December 1, 2023. This is a delivery order contract with a firm fixed price pricing type. The contract is not set aside for any...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the supply of Buprenorphine 20 mcg/hr patches. The $1,033.34 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA) and has a completion date of September 26, 2022. The contract is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, valued at $4,309.74, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,555,497,090 units of Buprenorphine 15 MCG/HR Patch 4S, a specialty medication used for pain management. This award is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $2,178.60, is for the delivery of Buprenorphine 20 MCG/HR Patch 4S, a pharmaceutical product, to support military and government healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026....
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FB11L
    Delivery Order

This federal contract award is for the delivery of Buprenorphine 15 MCG/HR Patch 4S, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,162.20 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 19, 2025, with a period of performance through February 20, 2025. The contract is a Delivery Order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 5/22/25, 8:35 PM